Cargando…
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510425/ https://www.ncbi.nlm.nih.gov/pubmed/33011643 http://dx.doi.org/10.1016/j.jcv.2020.104650 |
_version_ | 1783585784238964736 |
---|---|
author | Nörz, Dominik Frontzek, André Eigner, Ulrich Oestereich, Lisa Wichmann, Dominic Kluge, Stefan Fischer, Nicole Aepfelbacher, Martin Pfefferle, Susanne Lütgehetmann, Marc |
author_facet | Nörz, Dominik Frontzek, André Eigner, Ulrich Oestereich, Lisa Wichmann, Dominic Kluge, Stefan Fischer, Nicole Aepfelbacher, Martin Pfefferle, Susanne Lütgehetmann, Marc |
author_sort | Nörz, Dominik |
collection | PubMed |
description | BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In this study we evaluate clinical performance and linear range for the SARS-CoV-2 IVD (cobas6800/8800 system, a fully automated sample-to-result platform) in different clinically relevant matrix materials outside official specifications. METHODS: Assay performance was assessed in human plasma, BAL/BL and transport medium following chemical inactivation. For analytical evaluation, respective matrix materials were spiked with SARS-CoV-2 RNA in ten-fold dilution series. The efficacy of chemical inactivation by guanidine hydrochloride solution was confirmed in cell culture infectivity experiments. For correlation, a total of 289 predetermined clinical samples including respiratory swabs, plasma and lower respiratory tract specimens were subjected to the SARS-CoV-2 IVD test and results were compared. RESULTS: The SARS-CoV-2 IVD showed excellent linearity over four to six log steps depending on matrix material. Chemical inactivation resulted in a reduction in plaque forming units of at least 3.5 log steps, while having no significant impact on assay performance. Inter-run consistency from three different testing sites demonstrated excellent comparability of RT-PCR results (maximum deviation was 1.53 CT). Clinical evaluation for respiratory swabs showed very good agreement with the comparator assay (Positive agreement 95.7 %, negative agreement 98.9 %). CONCLUSION: The SARS-CoV-2 IVD test for the cobas6800/8800 systems offers excellent linear range and inter-run consistency for quantification of SARS-CoV-2 RNA in different matrices outside official specifications. |
format | Online Article Text |
id | pubmed-7510425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75104252020-09-24 Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations Nörz, Dominik Frontzek, André Eigner, Ulrich Oestereich, Lisa Wichmann, Dominic Kluge, Stefan Fischer, Nicole Aepfelbacher, Martin Pfefferle, Susanne Lütgehetmann, Marc J Clin Virol Article BACKGROUND: The ongoing SARS-CoV-2 pandemic presents a unique challenge to diagnostic laboratories. There are preliminary studies correlating qRT-PCR results from different materials to clinical outcomes, yet, comparability is limited due to the plethora of different assays used for diagnostics. In this study we evaluate clinical performance and linear range for the SARS-CoV-2 IVD (cobas6800/8800 system, a fully automated sample-to-result platform) in different clinically relevant matrix materials outside official specifications. METHODS: Assay performance was assessed in human plasma, BAL/BL and transport medium following chemical inactivation. For analytical evaluation, respective matrix materials were spiked with SARS-CoV-2 RNA in ten-fold dilution series. The efficacy of chemical inactivation by guanidine hydrochloride solution was confirmed in cell culture infectivity experiments. For correlation, a total of 289 predetermined clinical samples including respiratory swabs, plasma and lower respiratory tract specimens were subjected to the SARS-CoV-2 IVD test and results were compared. RESULTS: The SARS-CoV-2 IVD showed excellent linearity over four to six log steps depending on matrix material. Chemical inactivation resulted in a reduction in plaque forming units of at least 3.5 log steps, while having no significant impact on assay performance. Inter-run consistency from three different testing sites demonstrated excellent comparability of RT-PCR results (maximum deviation was 1.53 CT). Clinical evaluation for respiratory swabs showed very good agreement with the comparator assay (Positive agreement 95.7 %, negative agreement 98.9 %). CONCLUSION: The SARS-CoV-2 IVD test for the cobas6800/8800 systems offers excellent linear range and inter-run consistency for quantification of SARS-CoV-2 RNA in different matrices outside official specifications. Elsevier B.V. 2020-11 2020-09-23 /pmc/articles/PMC7510425/ /pubmed/33011643 http://dx.doi.org/10.1016/j.jcv.2020.104650 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Nörz, Dominik Frontzek, André Eigner, Ulrich Oestereich, Lisa Wichmann, Dominic Kluge, Stefan Fischer, Nicole Aepfelbacher, Martin Pfefferle, Susanne Lütgehetmann, Marc Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title | Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title_full | Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title_fullStr | Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title_full_unstemmed | Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title_short | Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations |
title_sort | pushing beyond specifications: evaluation of linearity and clinical performance of the cobas 6800/8800 sars-cov-2 rt-pcr assay for reliable quantification in blood and other materials outside recommendations |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510425/ https://www.ncbi.nlm.nih.gov/pubmed/33011643 http://dx.doi.org/10.1016/j.jcv.2020.104650 |
work_keys_str_mv | AT norzdominik pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT frontzekandre pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT eignerulrich pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT oestereichlisa pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT wichmanndominic pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT klugestefan pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT fischernicole pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT aepfelbachermartin pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT pfefferlesusanne pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations AT lutgehetmannmarc pushingbeyondspecificationsevaluationoflinearityandclinicalperformanceofthecobas68008800sarscov2rtpcrassayforreliablequantificationinbloodandothermaterialsoutsiderecommendations |